Annual FCF
-$22.21 M
+$4.49 M+16.82%
31 December 2023
Summary:
CASI Pharmaceuticals annual free cash flow is currently -$22.21 million, with the most recent change of +$4.49 million (+16.82%) on 31 December 2023. During the last 3 years, it has risen by +$20.13 million (+47.55%). CASI annual FCF is now -882.39% below its all-time high of -$2.26 million, reached on 31 December 2012.CASI Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
N/A
01 September 2024
Summary:
CASI Pharmaceuticals quarterly free cash flow is not available.CASI Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
N/A
01 September 2024
Summary:
CASI Pharmaceuticals TTM free cash flow is not available.CASI TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CASI Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | +47.5% | - | - |
| 5 y5 years | +40.4% | - | - |
CASI Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +47.5% | ||||
| 5 y | 5 years | at high | +50.9% | ||||
| alltime | all time | -882.4% | +58.8% |
CASI Pharmaceuticals Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | -$22.21 M(-16.8%) | - | - |
| Dec 2022 | -$26.70 M(-36.9%) | -$4.27 M(-38.9%) | -$26.70 M(-24.3%) |
| Sept 2022 | - | -$6.99 M(-21.6%) | -$35.29 M(+0.9%) |
| June 2022 | - | -$8.91 M(+36.6%) | -$34.98 M(+1.7%) |
| Mar 2022 | - | -$6.53 M(-49.2%) | -$34.39 M(-18.8%) |
| Dec 2021 | -$42.34 M(-6.3%) | -$12.86 M(+92.3%) | -$42.34 M(-5.5%) |
| Sept 2021 | - | -$6.69 M(-19.6%) | -$44.80 M(-19.7%) |
| June 2021 | - | -$8.32 M(-42.6%) | -$55.80 M(+1.4%) |
| Mar 2021 | - | -$14.48 M(-5.4%) | -$55.06 M(+21.8%) |
| Dec 2020 | -$45.21 M(+21.3%) | -$15.31 M(-13.4%) | -$45.21 M(+6.4%) |
| Sept 2020 | - | -$17.69 M(+133.6%) | -$42.50 M(+43.5%) |
| June 2020 | - | -$7.57 M(+63.4%) | -$29.61 M(-18.7%) |
| Mar 2020 | - | -$4.63 M(-63.2%) | -$36.43 M(-2.2%) |
| Dec 2019 | -$37.26 M(-26.0%) | -$12.60 M(+162.1%) | -$37.26 M(-11.5%) |
| Sept 2019 | - | -$4.81 M(-66.6%) | -$42.11 M(+1.4%) |
| June 2019 | - | -$14.39 M(+163.1%) | -$41.54 M(+33.6%) |
| Mar 2019 | - | -$5.47 M(-68.7%) | -$31.10 M(-38.2%) |
| Dec 2018 | -$50.36 M(+586.4%) | -$17.45 M(+312.7%) | -$50.36 M(+44.7%) |
| Sept 2018 | - | -$4.23 M(+7.1%) | -$34.79 M(+7.8%) |
| June 2018 | - | -$3.95 M(-84.0%) | -$32.28 M(+5.8%) |
| Mar 2018 | - | -$24.73 M(+1212.6%) | -$30.50 M(+315.7%) |
| Dec 2017 | -$7.34 M(+17.5%) | -$1.88 M(+9.5%) | -$7.34 M(+3.5%) |
| Sept 2017 | - | -$1.72 M(-20.7%) | -$7.09 M(+0.6%) |
| June 2017 | - | -$2.17 M(+38.6%) | -$7.05 M(+11.8%) |
| Mar 2017 | - | -$1.56 M(-4.5%) | -$6.31 M(+1.0%) |
| Dec 2016 | -$6.25 M(+12.8%) | -$1.64 M(-2.3%) | -$6.25 M(+5.8%) |
| Sept 2016 | - | -$1.68 M(+17.5%) | -$5.90 M(+2.6%) |
| June 2016 | - | -$1.43 M(-5.1%) | -$5.75 M(-1.3%) |
| Mar 2016 | - | -$1.50 M(+16.4%) | -$5.83 M(+5.3%) |
| Dec 2015 | -$5.54 M(+24.1%) | -$1.29 M(-15.5%) | -$5.54 M(+2.7%) |
| Sept 2015 | - | -$1.53 M(+1.6%) | -$5.39 M(+5.2%) |
| June 2015 | - | -$1.51 M(+24.3%) | -$5.13 M(+8.1%) |
| Mar 2015 | - | -$1.21 M(+5.5%) | -$4.74 M(+6.2%) |
| Dec 2014 | -$4.46 M(+34.4%) | -$1.15 M(-9.1%) | -$4.46 M(+10.0%) |
| Sept 2014 | - | -$1.26 M(+12.7%) | -$4.05 M(-2.7%) |
| June 2014 | - | -$1.12 M(+20.1%) | -$4.17 M(+1.7%) |
| Mar 2014 | - | -$932.20 K(+26.0%) | -$4.10 M(+23.5%) |
| Dec 2013 | -$3.32 M(+46.8%) | -$740.00 K(-46.2%) | -$3.32 M(-0.7%) |
| Sept 2013 | - | -$1.38 M(+31.0%) | -$3.34 M(+4.5%) |
| June 2013 | - | -$1.05 M(+586.3%) | -$3.20 M(-4.9%) |
| Mar 2013 | - | -$153.00 K(-79.9%) | -$3.36 M(+48.7%) |
| Dec 2012 | -$2.26 M(-47.2%) | -$762.90 K(-38.0%) | -$2.26 M(-5.9%) |
| Sept 2012 | - | -$1.23 M(+1.3%) | -$2.40 M(-18.9%) |
| June 2012 | - | -$1.21 M(-228.3%) | -$2.96 M(-21.8%) |
| Mar 2012 | - | $946.80 K(-204.6%) | -$3.79 M(-11.4%) |
| Dec 2011 | -$4.28 M(-13.8%) | -$905.50 K(-49.4%) | -$4.28 M(-7.8%) |
| Sept 2011 | - | -$1.79 M(-12.3%) | -$4.64 M(-7.4%) |
| June 2011 | - | -$2.04 M(-545.2%) | -$5.01 M(-4.4%) |
| Mar 2011 | - | $458.50 K(-136.2%) | -$5.24 M(+5.5%) |
| Dec 2010 | -$4.96 M(-51.4%) | -$1.27 M(-41.4%) | -$4.96 M(-7.3%) |
| Sept 2010 | - | -$2.16 M(-4.8%) | -$5.35 M(-15.6%) |
| June 2010 | - | -$2.27 M(-409.4%) | -$6.35 M(-19.3%) |
| Mar 2010 | - | $733.40 K(-144.3%) | -$7.86 M(-23.0%) |
| Dec 2009 | -$10.22 M | -$1.66 M(-47.5%) | -$10.21 M(-1.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2009 | - | -$3.15 M(-16.8%) | -$10.38 M(-27.7%) |
| June 2009 | - | -$3.79 M(+134.6%) | -$14.36 M(-20.7%) |
| Mar 2009 | - | -$1.62 M(-11.5%) | -$18.12 M(-13.1%) |
| Dec 2008 | -$20.85 M(-11.8%) | -$1.83 M(-74.4%) | -$20.85 M(-8.3%) |
| Sept 2008 | - | -$7.13 M(-5.5%) | -$22.72 M(+0.5%) |
| June 2008 | - | -$7.55 M(+73.6%) | -$22.62 M(-3.4%) |
| Mar 2008 | - | -$4.35 M(+17.4%) | -$23.43 M(-0.9%) |
| Dec 2007 | -$23.63 M(+12.5%) | -$3.70 M(-47.3%) | -$23.63 M(-5.0%) |
| Sept 2007 | - | -$7.02 M(-15.9%) | -$24.88 M(+5.3%) |
| June 2007 | - | -$8.35 M(+83.5%) | -$23.63 M(+17.8%) |
| Mar 2007 | - | -$4.55 M(-8.0%) | -$20.06 M(-4.5%) |
| Dec 2006 | -$21.00 M(+42.2%) | -$4.95 M(-14.4%) | -$21.00 M(+6.1%) |
| Sept 2006 | - | -$5.78 M(+20.8%) | -$19.79 M(+8.4%) |
| June 2006 | - | -$4.78 M(-12.9%) | -$18.26 M(-5.5%) |
| Mar 2006 | - | -$5.49 M(+46.8%) | -$19.33 M(+30.9%) |
| Dec 2005 | -$14.77 M(-10.9%) | -$3.74 M(-11.9%) | -$14.77 M(+9.6%) |
| Sept 2005 | - | -$4.24 M(-27.5%) | -$13.47 M(+5.0%) |
| June 2005 | - | -$5.85 M(+531.0%) | -$12.83 M(+14.0%) |
| Mar 2005 | - | -$927.90 K(-62.0%) | -$11.26 M(-32.1%) |
| Dec 2004 | -$16.57 M(-31.8%) | -$2.44 M(-32.2%) | -$16.57 M(-3.8%) |
| Sept 2004 | - | -$3.60 M(-15.8%) | -$17.22 M(-2.2%) |
| June 2004 | - | -$4.28 M(-31.4%) | -$17.61 M(-15.3%) |
| Mar 2004 | - | -$6.24 M(+102.0%) | -$20.80 M(-14.3%) |
| Dec 2003 | -$24.28 M(-47.3%) | -$3.09 M(-22.6%) | -$24.28 M(-1.4%) |
| Sept 2003 | - | -$3.99 M(-46.6%) | -$24.63 M(-8.6%) |
| June 2003 | - | -$7.47 M(-23.1%) | -$26.94 M(-23.4%) |
| Mar 2003 | - | -$9.72 M(+183.0%) | -$35.19 M(-23.7%) |
| Dec 2002 | -$46.09 M(-14.4%) | -$3.44 M(-45.5%) | -$46.09 M(-23.4%) |
| Sept 2002 | - | -$6.30 M(-59.9%) | -$60.18 M(-7.7%) |
| June 2002 | - | -$15.72 M(-23.8%) | -$65.18 M(+3.8%) |
| Mar 2002 | - | -$20.63 M(+17.7%) | -$62.77 M(+16.5%) |
| Dec 2001 | -$53.86 M(+17.4%) | -$17.53 M(+55.1%) | -$53.86 M(+17.3%) |
| Sept 2001 | - | -$11.30 M(-15.2%) | -$45.91 M(-1.8%) |
| June 2001 | - | -$13.32 M(+13.6%) | -$46.73 M(+4.2%) |
| Mar 2001 | - | -$11.72 M(+22.3%) | -$44.85 M(-2.3%) |
| Dec 2000 | -$45.89 M(+21.7%) | -$9.58 M(-21.0%) | -$45.89 M(-7.5%) |
| Sept 2000 | - | -$12.12 M(+6.0%) | -$49.61 M(+9.4%) |
| June 2000 | - | -$11.44 M(-10.4%) | -$45.34 M(+6.2%) |
| Mar 2000 | - | -$12.76 M(-4.1%) | -$42.68 M(+13.2%) |
| Dec 1999 | -$37.70 M(+163.6%) | -$13.30 M(+69.5%) | -$37.70 M(+32.3%) |
| Sept 1999 | - | -$7.85 M(-10.5%) | -$28.50 M(+12.9%) |
| June 1999 | - | -$8.77 M(+12.7%) | -$25.25 M(+41.2%) |
| Mar 1999 | - | -$7.78 M(+89.8%) | -$17.88 M(+25.0%) |
| Dec 1998 | -$14.30 M(+88.2%) | -$4.10 M(-10.9%) | -$14.30 M(+21.2%) |
| Sept 1998 | - | -$4.60 M(+228.6%) | -$11.80 M(+20.4%) |
| June 1998 | - | -$1.40 M(-66.7%) | -$9.80 M(+4.3%) |
| Mar 1998 | - | -$4.20 M(+162.5%) | -$9.40 M(+23.7%) |
| Dec 1997 | -$7.60 M(+216.7%) | -$1.60 M(-38.5%) | -$7.60 M(+15.2%) |
| Sept 1997 | - | -$2.60 M(+160.0%) | -$6.60 M(+6.5%) |
| June 1997 | - | -$1.00 M(-58.3%) | -$6.20 M(+113.8%) |
| Mar 1997 | - | -$2.40 M(+300.0%) | -$2.90 M(+20.8%) |
| Dec 1996 | -$2.40 M | -$600.00 K(-72.7%) | -$2.40 M(+33.3%) |
| Sept 1996 | - | -$2.20 M(-195.7%) | -$1.80 M(-550.0%) |
| June 1996 | - | $2.30 M(-221.1%) | $400.00 K(-121.1%) |
| Mar 1996 | - | -$1.90 M | -$1.90 M |
FAQ
- What is CASI Pharmaceuticals annual free cash flow?
- What is the all time high annual FCF for CASI Pharmaceuticals?
- What is the all time high quarterly FCF for CASI Pharmaceuticals?
- What is the all time high TTM FCF for CASI Pharmaceuticals?
What is CASI Pharmaceuticals annual free cash flow?
The current annual FCF of CASI is -$22.21 M
What is the all time high annual FCF for CASI Pharmaceuticals?
CASI Pharmaceuticals all-time high annual free cash flow is -$2.26 M
What is the all time high quarterly FCF for CASI Pharmaceuticals?
CASI Pharmaceuticals all-time high quarterly free cash flow is $2.30 M
What is the all time high TTM FCF for CASI Pharmaceuticals?
CASI Pharmaceuticals all-time high TTM free cash flow is $400.00 K